Osmosis Investment Management UK’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.04M Sell
61,663
-67,971
-52% -$12.3M 0.42% 57
2026
Q1
$19.1M Buy
129,634
+15,918
+14% +$2.59M 0.51% 46
2025
Q4
$22.2M Buy
+113,716
New +$27.1M 0.56% 34

Other funds holding ORCL

Osmosis Investment Management UK's ORCL Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Oracle (ORCL) stake by 52% in Q2 2026, selling an estimated $12.3M and leaving 61,663 shares worth $9.04M. The position accounts for 0.42% of the portfolio, ranked #57.

Osmosis Investment Management UK first reported a position in ORCL in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.2M in Q4 2025. 3,513 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Osmosis Investment Management UK held 61,663 shares of Oracle worth $9.04M as of Q2 2026.
  • Osmosis Investment Management UK sold 67,971 Oracle shares in Q2 2026, an estimated $12.3M.
  • Oracle made up 0.42% of Osmosis Investment Management UK's portfolio in Q2 2026, its #57 holding.
  • Osmosis Investment Management UK first reported a position in Oracle in Q4 2025 and has held it in 3 quarters since.
  • Osmosis Investment Management UK's Oracle position peaked at $22.2M in Q4 2025.
  • 3,513 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.